Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

[The relevant factors and strategies related efficacy with standard of care in chronic hepatitis C treatment naive patients].

Dou XG.

Zhonghua Gan Zang Bing Za Zhi. 2013 Jun;21(6):406-7. Chinese. No abstract available.

PMID:
24490300
2.

Ribavirin in chronic hepatitis C: past and future.

Loustaud-Ratti V, Rousseau A, Marquet P, Denis F, Alain S.

Expert Rev Anti Infect Ther. 2009 Apr;7(3):249-53. doi: 10.1586/eri.09.5. No abstract available.

PMID:
19344238
3.

A randomized trial to assess the efficacy of interferon-alpha daily in combination with ribavirin in the treatment of naïve patients with chronic hepatitis C.

Tassopoulos NC, Ketikoglou I, Tsantoulas D, Raptopoulou M, Hatzis G, Vafiadis I, Sidiropoulos L, Kanatakis S, Anagnostopoulos G, Sypsa V, Hatzakis A; Hellenic Viral Hepatitis Research Network.

J Viral Hepat. 2003 Sep;10(5):383-9.

PMID:
12969190
4.

[Pegylated interferon alpha-2a. Quality of life improves significantly during successful therapy].

[No authors listed]

MMW Fortschr Med. 2002 Nov 28;144(48):58-9. German. No abstract available.

PMID:
12532548
5.

[Chronic hepatitis C. Chances of healing good as never before].

[No authors listed]

MMW Fortschr Med. 2003 Oct 16;145(42):61. German. No abstract available.

PMID:
14655449
6.

[Treatment of patients with chronic hepatitis C who have not been previously treated].

Marcellin P, Boyer N.

Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B194-201. Review. French. No abstract available.

PMID:
12180288
7.

The pattern of response to interferon alpha (alpha-IFN) predicts sustained response to a 6-month alpha-IFN and ribavirin retreatment for chronic hepatitis C. TVVH Study Group.

Cavalletto L, Chemello L, Donada C, Casarin P, Belussi F, Bernardinello E, Marino F, Pontisso P, Gatta A, Alberti A.

J Hepatol. 2000 Jul;33(1):128-34.

PMID:
10905596
8.

Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.

Sostegni R, Ghisetti V, Pittaluga F, Marchiaro G, Rocca G, Borghesio E, Rizzetto M, Saracco G.

Hepatology. 1998 Aug;28(2):341-6.

PMID:
9695995
9.

An open-safety study of dual antiviral therapy in real-world patients with chronic hepatitis C.

Tinè F, Graviano D, Giannuoli G, Madonia S, Malizia G, Patti S, Fasola S, Cottone M, D'Amico G; at Liver Study Group of Villa Sofia-Cervello Hospital (LSVSCH).

Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1113-23. doi: 10.1002/pds.2025.

PMID:
20848397
10.

Infectious disease. Despite setbacks, optimism on drugs for hepatitis C.

Cohen J.

Science. 2012 Sep 21;337(6101):1450-1. No abstract available.

PMID:
22997303
11.

[Treatment for hepatitis C virus associated cryoglobulinemia with interferon alpha and ribavirin].

Altuna L, Fernández J, Castiella A.

Rev Esp Enferm Dig. 2005 Jul;97(7):531-2. Spanish. No abstract available.

12.

Statin therapy improves response to interferon alfa and ribavirin in chronic hepatitis C: a systematic review and meta-analysis.

Zhu Q, Li N, Han Q, Zhang P, Yang C, Zeng X, Chen Y, Lv Y, Liu X, Liu Z.

Antiviral Res. 2013 Jun;98(3):373-9. doi: 10.1016/j.antiviral.2013.04.009. Epub 2013 Apr 16. Review.

PMID:
23603497
13.

Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.

Soriano V, Núñez M, Camino N, Maida I, Barreiro P, Romero M, Martin-Carbonero L, Garcia-Samaniego J, González-Lahoz J.

Antivir Ther. 2004 Aug;9(4):505-9.

PMID:
15456081
14.

[Hepatitis C: therapeutic perspectives].

Trépo C.

Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B297-302. Review. French. No abstract available.

PMID:
12180304
15.

Interferon and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia.

Donada C, Crucitti A, Donadon V, Chemello L, Alberti A.

Blood. 1998 Oct 15;92(8):2983-4. No abstract available.

16.

[Difficult-to-treat patient with chronic hepatitis C: a challenge in clinical practice].

Dou XG.

Zhonghua Gan Zang Bing Za Zhi. 2009 Jul;17(7):486-7. Chinese. No abstract available.

PMID:
19912678
17.

[Treatment of chronic hepatitis C: present and future].

Hezode C, Dhumeaux D.

Gastroenterol Clin Biol. 2000 May;24(5):533-5. Review. French. No abstract available.

18.

[Treatment for chronic hepatitis C, more opportunity, more challenge].

Wei L.

Zhonghua Gan Zang Bing Za Zhi. 2009 Jul;17(7):481-3. Chinese. No abstract available.

PMID:
19912676
19.

[Treatment of chronic hepatitis C: interferon alpha-2b alone or in combination with ribavirin].

Fontaine H, Pol S.

Gastroenterol Clin Biol. 1999 Apr;23(4):541-4. French. No abstract available.

Supplemental Content

Support Center